For the Quarter Ending December 2022
North American region, particularly the USA, witnessed an inclined price trend for Clindamycin Phosphate during the start of October. Increased end-user demand balanced with enough supplies among the market participants kept the prices of Clindamycin Phosphate on the higher side. Slowing economic activity amid rising borrowing costs, Consumer spending, which edged up 0.1% after surging 0.9% in October, and ease in trade disruption along with shipment cost supported the market sentiments of Clindamycin Phosphate in the USA. Until November, the cost of Clindamycin Phosphate got settled at USD 146520/MT CFR Los Angeles in the USA. Towards the end of the fourth quarter of 2022, the prices fell significantly, backed by decremented inquiries coupled with the temporary shutdown of the domestic market owing to New-year holidays.
The prices of Clindamycin Phosphate plummeted at the end of 2022 in the Asia Pacific region, primarily in China. At the start of the fourth quarter, the market of Clindamycin Phosphate visualized a positive market outlook as the demand inclined considerably following the trend of the previous month. Following November, the ease in supply disruption and port congestion at the importing countries additionally supported the price trends of Clindamycin Phosphate and got settled at USD 145255/MT FOB Shanghai. With the start of December, demand in China remains largely dormant, as an outburst of lockdowns of COVID-19 has muted economic output and affected the market sentiments of all the commodities, including Clindamycin Phosphate in China.
During the fourth quarter of 2022, the European market for Clindamycin Phosphate imitated a similar pattern as that of APAC. The market initially started on a healthy note up to November as the demand from the end-user sector of the pharmaceutical industry increased, which was balanced with the overall supplies among the market participants. After November, the witnesses for the Clindamycin Phosphate pricing were gathered at USD 150640/MT CFR Hamburg. Additionally, in November, the downstream industry started to moderately raise its requests for rates on Clindamycin Phosphate, which helped to keep prices on the higher side. Fresher orders decreased in December of 2022 due to suppliers having high stock levels due to the market's brief closure.
For the Quarter Ending September 2022
The Clindamycin Phosphate market showcased decremented pricing sentiments during the third quarter of 2022 in the North American region. The Clindamycin Phosphate prices in the United States declined throughout the Q3, backed by reduced demand from the downstream pharmaceutical industries amidst weak purchasing activities and overflowing inventories from domestic merchants. Furthermore, the fluctuation in energy values and freight charges also led to the instability in the price of Clindamycin Phosphate. By the termination of the third quarter, the prices of Clindamycin phosphate demonstrated a declined trend with 2.34 percent and got settled at USD 137590/MT CFR Los Angeles.
During the third quarter of 2022, Clindamycin Phosphate prices witnessed considerable growth in the APAC region. The price of Clindamycin Phosphate went down poorly in the first and mid of q3, but it then inclined significantly towards the termination of mid of q3. Additionally, supply disruption and higher demand in the market supported the price tendency of Clindamycin Phosphate API in the overall market. Also, trade disruption, cargo shortage, and rerouting activity affected the price of Clindamycin Phosphate in the market, keeping it on the higher side. Furthermore, towards the termination of the third quarter, the prices recorded for Clindamycin Phosphate were settled at USD 135655/MT FOB Shanghai in China.
The prices of Clindamycin Phosphate in the European region witnessed a declining trend during the q3 of 2022, following the trend of North America. Supply and demand fundamentals witnessed were on the weaker side, resulting in downstream stockpiling with the domestic merchants. Additionally, fluctuations in trade frequency from China during the whole quarter also affected the market value of Clindamycin Phosphate. Also, the slow offtake from downstream pharmaceuticals was one of the factors behind this weak price trend of Clindamycin Phosphate in Germany. Thus, with the end of q3, the prices of Clindamycin Phosphate settled at USD 145280/MT CFR Hamburg.
North American market witnessed a continual rise in the prices of Clindamycin Phosphate API during the second Quarter of 2022, backed by enhanced downstream demand from various pharmaceutical and biopharmaceutical sectors. Besides that, rerouting activities and import facilities leading to delayed shipments in the international market affected the prices of Clindamycin phosphate. Also, the gradual increase in feedstock cost from various importing countries resulted in the price enhancement of downstream Clindamycin Phosphate API in the market. Additionally, insufficient stocks with the traders caused heightened production activities with surging demand, which in turn was another factor that led to API's price increment..With the termination of second quarter the prices recorded for Clindamycin Phosphate were settled at USD 146820/MT with an average inclination of 2.34 percent in US.
During the Second Quarter, the Clindamycin Phosphate market witnessed significant growth in the APAC region. The price of Clindamycin Phosphate went high because the demand side exceeded the market's supply side. urther, higher upstream feed prices caused the cost to spike high of downstream clindamycin phosphate in the regional and domestic markets. In addition, supply disruption and labor shortage due to higher demand in the market added another reason for the price enhancement of API in the market. Also, trade disruption, cargo shortage, and rerouting activity affected the price value of Clindamycin Phosphate in the market.Towards the termination of second quarter the prices recorded for Clindamycin Phosphate were settled at USD 135820/MT FOB Shanghai in China.
During the Second Quarter of 2022, the European region showcased a similar market sentiment for Clindamycin Phosphate to the North American region. An increase in downstream demand from various pharmaceutical sectors was one of the important factors that drove Clindamycin Phosphate API price value in the market. Furthermore, the prices went high significantly as China being the major exporter of API, increasing covid cases resulted in a temporary shutdown of manufacturing units in Shanghai and Beijing, affecting the trading activities, which in turn affected the prices of Clindamycin Phosphate all over the region. Additionally, higher freight charges, owing to the shortage of cargo, affected the cost of Clindamycin Phosphate further. Towards the termination of second quarter the prices recorded for Clindamycin Phosphate were settled at USD 154820/MT CFR Hamburgin Germany.